Vertex Pharmaceuticals
VRTX
394,15 €
Share price
-1.00%
Change (1 day)
-11.64%
Change (1 year)
Categories
Vertex Pharmaceuticals (VRTX) - Net assets
Net assets on the balance sheet as of March 2025 : €14.27 Billion
According to Vertex Pharmaceuticals's latest financial reports the company has €14.27 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Vertex Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $€15.76 B | -0.84% |
| 2023-12-31 | $€15.90 B | 22.61% |
| 2022-12-31 | $€12.97 B | 45.43% |
| 2021-12-31 | $€8.91 B | 26.28% |
| 2020-12-31 | $€7.06 B | 30.01% |
| 2019-12-31 | $€5.43 B | 40.11% |
| 2018-12-31 | $€3.87 B | 127.77% |
| 2017-12-31 | $€1.70 B | 33.79% |
| 2016-12-31 | $€1.27 B | 27.2% |
| 2015-12-31 | $€1.00 B | 10.97% |
| 2014-12-31 | $€0.90 B | -8.23% |
| 2013-12-31 | $€0.98 B | 8.64% |
| 2012-12-31 | $€0.90 B | 26.45% |
| 2011-12-31 | $€0.71 B | 88.7% |
| 2010-12-31 | $€0.37 B | -50.49% |
| 2009-12-31 | $€0.76 B | 347.84% |
| 2008-12-31 | $€0.17 B | -8.04% |
| 2007-12-31 | $€0.18 B | -51.54% |
| 2006-12-31 | $€0.38 B | 89.91% |
| 2005-12-31 | $€0.20 B | 672.79% |
| 2004-12-31 | $€26.12 M | -82.94% |
| 2003-12-31 | $€0.15 B | -57.71% |
| 2002-12-31 | $€0.36 B | -32.72% |
| 2001-12-31 | $€0.53 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | €16.51 B | 15.65% | 🇺🇸 USA |
 AbbVie ABBV | €1.26 B | -91.14% | 🇺🇸 USA |
 Merck MRK | €41.88 B | 193.40% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | €15.09 B | 5.77% | 🇺🇸 USA |
 Johnson & Johnson JNJ | €67.59 B | 373.49% | 🇺🇸 USA |
 Enanta Pharmaceuticals
ENTA | €80.94 M | -99.43% | 🇺🇸 USA |